IJNRD Research Journal

WhatsApp
Click Here

WhatsApp editor@ijnrd.org
IJNRD
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.76

Issue per Year : 12

Volume Published : 9

Issue Published : 95

Article Submitted :

Article Published :

Total Authors :

Total Reviewer :

Total Countries :

Indexing Partner

Join RMS/Earn 300

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: TO DEVELOP AN ALTERNATE EFFICIENT MICROPARTICULATE SYSTEM(S) FOR ANTITUBERCULAR DRUG(S) BY ENGINEERING THE SURFACE OF PARTICLES TO REACH MYCOBACTERIUM INTRACELLULARLY
Authors Name: Kanchan Galgate
Download E-Certificate: Download
Author Reg. ID:
IJNRD_184687
Published Paper Id: IJNRD2212085
Published In: Volume 7 Issue 12, December-2022
DOI:
Abstract: Due to its status as the biggest infectious disease killer globally, along with HIV infection, tuberculosis (TB) continues to be a serious global health concern (HIV). A important opportunistic illness among people with a high incidence of AIDS is tuberculosis (TB). Mycobacterium tuberculosis (MTB), which causes TB, is a lethal infectious illness that primarily affects the respiratory system. Meningitis, circulatory tuberculosis, lymphatic tuberculosis, genitourinary tuberculosis, bones, and joints are other major public health concerns caused by MTB. Pharmacokinetic event showed that an experimental carrier's drug plasma profile is significantly influenced by the physico-chemical properties of the polymer. Tmax for RIF (Free) was found to be 2.890.31hr, whereas Tmax for the chitosan ascorbate formulation was found to be 13.250.01hr and 16.410.81hr for C3S3P4T2R and C3S3P4T2I, respectively. The results make it abundantly apparent that MMAD did not significantly change when the formulations were kept in a refrigerator. Although the MMAD significantly varied when the formulations were held at room temperature, it nevertheless stayed within the range of respirable particles that alveolar macrophages can effectively absorb. The amount of drug that has been incorporated into the formulation determines its therapeutic impact; as a result, the residual drug content was tracked and contrasted with the results from the stability testing phase. The results suggested that the conjugation with ligand greatly decreased the leaching of medication from formulations. This finding may be related to the bulky group on the surface of microspheres, which may have prevented some drug leakage.
Keywords: Rifampicin, Chitosan, antitubercular drug, In-vivo study
Cite Article: "TO DEVELOP AN ALTERNATE EFFICIENT MICROPARTICULATE SYSTEM(S) FOR ANTITUBERCULAR DRUG(S) BY ENGINEERING THE SURFACE OF PARTICLES TO REACH MYCOBACTERIUM INTRACELLULARLY", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.7, Issue 12, page no.a625-a641, December-2022, Available :http://www.ijnrd.org/papers/IJNRD2212085.pdf
Downloads: 000118744
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID:IJNRD2212085
Registration ID: 184687
Published In: Volume 7 Issue 12, December-2022
DOI (Digital Object Identifier):
Page No: a625-a641
Country: Ahmednagar, maharashtra, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2212085
Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2212085
Share Article:
Share

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijnrd.org
Semantic Scholar Microsaoft Academic ORCID Zenodo
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX PUBLON
DRJI SSRN Scribd DocStoc

ISSN Details

ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI
How to Get DOI? DOI

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Join RMS/Earn 300

IJNRD